Novo Says Still Some Uncertainty on Tresiba Costs

Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)

Full Show: Bloomberg Markets Middle East 07/24
34:47 - Full episode of "Bloomberg Markets Middle East." Guests include: Tarek Fadlallah, chief executive officer at Nomura Asset Management Middle East, and Jesse Downs, managing director at Phidar Advisory. (Source: Bloomberg)
  • Is It Time for the Bank of Japan to Move?
  • Nintendo Shares Plunge: What's Behind the Drop?
  • Turkey Plans Infrastructure Fund to Keep Growth on Track